Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-12-15
1993-09-14
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514299, A61K 3144
Patent
active
052449092
ABSTRACT:
The invention relates to the use of certain compounds which act as antagonists of 5-hydroxytryptamine (5-HT) at 5-HT.sub.3 receptors for the treatment of cognitive disorders such as attentional and memory deficits and dementia states.
REFERENCES:
patent: 4624961 (1986-11-01), Welstead, Jr.
patent: 4721720 (1988-01-01), Wootton et al.
patent: 4789673 (1988-12-01), Donatsch et al.
patent: 4803199 (1989-02-01), Donatsch et al.
patent: 4851407 (1989-07-01), Wooton et al.
Altman et al., Psychopharmacology, 90, 24-27 (1986).
Essman, Advances in Biochemical Psychopharmacology, 11, 265-274 (1974).
Glaxo Group Limited
Henley III Raymond J.
Waddell Frederick E.
LandOfFree
Methods for the treatment of cognitive disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of cognitive disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of cognitive disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2026799